Abstract: One illustrative method involves the steps of receiving a ciphering mode information message from a wireless network; identifying and processing valid radio bearer downlink ciphering activation time information in the ciphering mode information message when it is part of a security mode command message; and refraining from processing any valid radio bearer downlink ciphering activation time information in the ciphering mode information message when it is part of a message that is different from the security mode command message (i.e. when it is part of a radio network subsystem relocation procedure).

Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.

Abstract: In accordance with the teachings described herein, systems and methods are provided for configuring signaling radio bearer information in a user equipment protocol stack. A wireless network may be used that includes a radio access network for transmitting information between a user equipment device and a core network. An instruction may be received to generate a signaling radio bearer configuration information element (IE) that includes configuration information for a pre-selected number of signaling radio bearers. The signaling radio bearer configuration IE may then be generated, while ensuring that the signaling radio bearer configuration IE includes configuration information for a required minimum number of signaling radio bearers. The signaling radio bearer configuration information element may be transmitted from the radio access network to the user equipment device for use in configuring the signaling radio bearers in the user equipment device.

Abstract: Methods and apparatus for use in reducing airlink congestion and processing time associated with ciphering information communicated between a wireless communication network and a mobile station are disclosed. From the standpoint of the mobile station, one illustrative method involves the steps of receiving a ciphering mode information message from a wireless network; identifying and processing valid radio bearer downlink ciphering activation time information in the ciphering mode information message when it is part of a security mode command message; and refraining from processing any valid radio bearer downlink ciphering activation time information in the ciphering mode information message when it is part of a message that is different from the security mode command message (i.e. when it is part of a radio network subsystem relocation procedure).

Abstract: The invention provides therapeutic anti-beta7 antibodies, compositions comprising, and methods of using these antibodies.

Abstract: Peptide ligands having affinity for serum albumin are useful for tumor targeting. Conjugate molecules comprising a serum albumin binding peptide fused to a biologically active molecule demonstrate modified pharmacokinetic properties as compared with the biologically active molecule alone, including tissue (e.g., tumor) uptake, infiltration, and diffusion.

Abstract: The invention provides variant hypervariable regions comprising selected amino acid sequence diversity. Libraries comprising a plurality of these polypeptides are also provided. In addition, methods of and compositions for generating and using these polypeptides and libraries are provided.

Abstract: Peptide ligands having affinity for IgG or for serum albumin are disclosed. Also disclosed are hybrid molecules comprising a peptide ligand domain and an active domain. The active domain may comprise any molecule having utility as a therapeutic or diagnostic agent The hybrid molecules of the invention may be prepared using any of a number techniques including production in and purification from recombinant organisms transformed or transfected with an isolated nucleic acid encoding the hybrid molecule, or by chemical synthesis of the hybrid. The hybrid molecules have utility as agents to alter the elimination half-times of active domain molecules. Elimination half-time is altered by generating a hybrid molecule of the present invention wherein the peptide ligand has binding affinity for a plasma protein.

Abstract: A method and apparatus for calculating an initial transmission power in a mobile telecommunications system is disclosed, the system comprising a network of a plurality of cells and at least one user equipment device. The user equipment device receives broadcast system information, and measures a signal power. An initial transmission power is calculated in a lowest logical layer of the system defined as a protocol stack, using the received information and measured power.

Abstract: The invention provides therapeutic anti-c-met antibodies, and compositions comprising and methods of using these antibodies.

Abstract: Methods and apparatus for initiating the release of an IP address allocated for use by a Mobile Node supporting Mobile IP are disclosed. The IP address may be a collocated care-of address or a dynamically assigned home address. The release of the IP address may be initiated by the Home Agent based upon information it has received in a registration request or, alternatively, may be initiated by the Home Agent in response to a de-registration request. In this manner, a Home Agent may initiate the release of an IP address that is no longer in use by a Mobile Node.

Abstract: Peptide ligands having affinity for serum albumin are useful for tumor targeting. Conjugate molecules comprising a serum albumin binding peptide fused to a biologically active molecule demonstrate modified pharmacokinetic properties as compared with the biologically active molecule alone, including tissue (e.g., tumor) uptake, infiltration, and diffusion.

Abstract: A modular display system having individual stackable electronic display panels of convenient and portable size and mounting structures for the support thereof where the stackable electronic display panels mutually juxtapose, mate, and robustly and mutually and adjustably secure together by the use of connector plates at the top of stackable electronic display panels interfacing with interlocking lower connector assemblies and lower connector plate receptors at the bottom of an overhead vertically situated stackable electronic display panel and by interfacing of latches and cams of latch keeper assemblies at the sides of horizontally situated stackable electronic display panels to form a large electronic sign display. Spring-loaded slide pin assemblies foster rapid and secure connection between vertically situated stackable electronic display panels. Adjustment features are also incorporated to align each stackable electronic display panel.

Abstract: Peptide ligands having affinity for serum albumin are useful for tumor targeting. Conjugate molecules comprising a serum albumin binding peptide fused to a biologically active molecule demonstrate modified pharmacokinetic properties as compared with the biologically active molecule alone, including tissue (e.g., tumor) uptake, infiltration, and diffusion.

Abstract: The invention provides therapeutic anti-c-met antibodies, and compositions comprising and methods of using these antibodies.

Abstract: The present application concerns restoring antigen binding during humanization of antibodies through the selection of repaired hypervariable regions rather than through framework changes.

Abstract: A technique is disclosed for synchronizing NAT information stored on different network devices that have been configured to implement a network address translation protocol. Each of the network devices includes a respective NAT data structure configured to store NAT information. The NAT information includes at least one NAT entry relating to a network node engaged in a communication session with at least one other network node. At least one NAT entry in a first NAT data structure is modified. The first NAT data structure is associated with a first NAT network device. A first NAT transaction message is generated which includes information relating to the modifications performed on the first NAT data structure. The first NAT transaction message is transmitted to at least one other NAT network device to thereby cause that device to modify its respective NAT data structure using information from the first NAT transaction message.

Abstract: A technique is disclosed for synchronizing NAT information stored on different network devices that have been configured to implement a network address translation protocol. Each of the network devices includes a respective NAT data structure configured to store NAT information. The NAT information includes at least one NAT entry relating to a network node engaged in a communication session with at least one other network node. At least one NAT entry in a first NAT data structure is modified. The first NAT data structure is associated with a first NAT network device. A first NAT transaction message is generated which includes information relating to the modifications performed on the first NAT data structure. The first NAT transaction message is transmitted to at least one other NAT network device to thereby cause that device to modify its respective NAT data structure using information from the first NAT transaction message.

Abstract: The invention provides therapeutic anti-beta7 antibodies, compositions comprising, and methods of using these antibodies.

Abstract: A method of controlling a hydronic system is provided. The hydronic system includes a plurality of fluid heat exchange units for feeding a load, and a bypass valve for bypassing the load. The method includes operating at least a first and a second fluid heat exchange unit in the hydronic system to heat or cool a fluid. An output fluid flow of each of the operating fluid heat exchange units is monitored. The monitored output fluid flow of each fluid heat exchange unit is compared to a predetermined fluid flow setpoint. The output fluid flow of each of the operating fluid heat exchange units is adjusted towards the predetermined fluid flow setpoint if the monitored output flow is different from the predetermined fluid flow setpoint by at least a predetermined margin. A combined output fluid flow of the operating fluid heat exchange units is also monitored. The bypass valve is at least partially opened if the combined output fluid flow is below a predetermined minimum combined output fluid flow.